# Akso Health Group: Form 20-F for the period ended Mar 31, 2018

- Company: [Akso Health Group](/companies/ahg.md) (CIK 1702318)
- Form: 20-F
- Filed: 2018-07-30
- Accepted by EDGAR: Jul 27, 2018, 18:21 ET
- Period: 2018-03-31
- Accession: 0001104659-18-047800
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1702318/000110465918047800/a18-14971_120f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1702318/000110465918047800/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Gross profit | 12 months, 2017-04-01 to 2018-03-31 | $107.3m | us-gaap:GrossProfit |
| Research and development | 12 months, 2017-04-01 to 2018-03-31 | $2.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2017-04-01 to 2018-03-31 | $75.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2017-04-01 to 2018-03-31 | $11.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2017-04-01 to 2018-03-31 | $65.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2017-04-01 to 2018-03-31 | $1.37 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2017-04-01 to 2018-03-31 | $1.46 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2017-04-01 to 2018-03-31 | 47,656,263 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2017-04-01 to 2018-03-31 | $87.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2017-04-01 to 2018-03-31 | $456.0k | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | at 2018-03-31 | $132.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | at 2018-03-31 | $163.9m | us-gaap:Assets |
| Total liabilities | at 2018-03-31 | $23.8m | us-gaap:Liabilities |
| Shareholders' equity | at 2018-03-31 | $140.0m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2018-03-31 | 47,958,550 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1702318/000110465918047800/a18-14971_120f.htm

Filed Jul 30, 2018.
Source: SEC EDGAR, the filing index for accession 0001104659-18-047800. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.